BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6414648)

  • 1. Characterization of some minor gangliosides in Tay-Sachs brains.
    Yu RK; Itoh T; Yohe HC; Macala LJ
    Brain Res; 1983 Sep; 275(1):47-52. PubMed ID: 6414648
    [No Abstract]   [Full Text] [Related]  

  • 2. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
    Rosengren B; Månsson JE; Svennerholm L
    J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
    Neuenhofer S; Conzelmann E; Schwarzmann G; Egge H; Sandhoff K
    Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M; Inui K; Hirabayashi Y; Tsukamoto H; Nishimoto J; Midorikawa M; Okada S; Yabuuchi H
    J Inherit Metab Dis; 1989; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y; Kasakura H; Matsumoto M
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract]   [Full Text] [Related]  

  • 6. Ganglioside-composition of brain in Tay-Sachs disease: increased amounts of GD2 and N-acetyl-beta-D-galactosaminyl GD1a ganglioside.
    Iwamori M; Nagai Y
    J Neurochem; 1979 Mar; 32(3):767-77. PubMed ID: 430057
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the accumulated ganglioside.
    Svennerholm L
    Adv Genet; 2001; 44():33-41. PubMed ID: 11596994
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycosphingolipids in fetal Tay-Sachs disease brain and lung cultures.
    Hoffman LM; Amsterdam D; Brooks SE; Schneck L
    J Neurochem; 1977 Sep; 29(3):551-9. PubMed ID: 894310
    [No Abstract]   [Full Text] [Related]  

  • 9. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
    Chen Y; Allegood J; Liu Y; Wang E; Cachón-Gonzalez B; Cox TM; Merrill AH; Sullards MC
    Anal Chem; 2008 Apr; 80(8):2780-8. PubMed ID: 18314967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate regulation of ganglioside glycosyltransferases in differentiating NG108-15 neuroblastoma x glioma cells.
    Walton KM; Schnaar RL
    J Neurochem; 1989 May; 52(5):1537-44. PubMed ID: 2540274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain gangliosides: an improved simple method for their extraction and identification.
    Randell JA; Pennock CA
    J Chromatogr; 1980 Jul; 195(2):257-64. PubMed ID: 6773970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain.
    Itoh T; Li YT; Li SC; Yu RK
    J Biol Chem; 1981 Jan; 256(1):165-9. PubMed ID: 7451432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
    Hoffman LM; Brooks SE; Stein MR; Adachi M; Schneck L
    Metab Brain Dis; 1989 Jun; 4(2):87-93. PubMed ID: 2547146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential scanning calorimetry study of the interaction of gangliosides with peanut lectin, serotonin and daunomycin.
    Bach D; Sela BA
    Biochim Biophys Acta; 1980 Feb; 596(2):186-91. PubMed ID: 7356996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization.
    Banerjee A; Burg J; Conzelmann E; Carroll M; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1984 Mar; 365(3):347-56. PubMed ID: 6724528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
    J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodate oxidation of glycolipids: a borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections.
    Buk SJ; High OB
    Histochem J; 1986 May; 18(5):228-32. PubMed ID: 3091539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines.
    Yamashiro S; Ruan S; Furukawa K; Tai T; Lloyd KO; Shiku H; Furukawa K
    Cancer Res; 1993 Nov; 53(22):5395-400. PubMed ID: 8221677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHROMATOGRAPHIC STUDIES OF NORMAL AND TAY-SACHS GANGLIOSIDES (PEPTIDE-STRANDIN).
    SAIFER A; ROBIN M; VOLK BW
    J Neurochem; 1963 Aug; 10():577-86. PubMed ID: 14062003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.